Table 3. Novel miRNA candidates differentially represented between morphs and/or developmental stages in the small-RNA-seq data.
Name | Expressed | SB1 | SB2 | SB3 | SB4 | AC1 | AC2 | AC3 | AC4 |
sal-nov_1 | Morph/Time | 7 | 4 | 1 | 1 | 17 | 31 | 25 | 10 |
sal-nov_2 | Morph | 8 | 13 | 16 | 9 | 104 | 89 | 151 | 88 |
sal-nov_3 | Morph | 34 | 78 | 63 | 17 | 0 | 0 | 0 | 0 |
sal-nov_4 | Morph | 0 | 0 | 0 | 0 | 13076 | 5397 | 5755 | 560 |
sal-nov_5 | Morph/Time | 0 | 0 | 0 | 0 | 1800 | 563 | 343 | 0 |
sal-nov_6 | Morph | 47 | 9 | 14 | 18 | 73 | 58 | 23 | 28 |
sal-nov_7 | Morph | 25 | 5 | 1 | 9 | 48 | 45 | 14 | 5 |
sal-nov_8 | Morph | 207 | 168 | 20 | 7 | 256 | 117 | 47 | 71 |
sal-nov_9 | Morph | 130 | 59 | 13 | 54 | 268 | 361 | 173 | 70 |
sal-nov_10 | Morph | 16 | 6 | 12 | 10 | 45 | 53 | 52 | 25 |
sal-nov_11 | Morph | 8 | 13 | 16 | 9 | 104 | 89 | 151 | 88 |
sal-nov_12 | Morph | 8 | 12 | 13 | 6 | 14 | 17 | 15 | 6 |
sal-nov_13 | Morph | 21 | 44 | 112 | 133 | 113 | 110 | 236 | 308 |
sal-nov_14 | Morph | 2 | 32 | 31 | 53 | 27 | 25 | 96 | 103 |
sal-nov_15 | Morph | 3 | 22 | 32 | 31 | 6 | 7 | 8 | 10 |
sal-nov_16 | Morph | 644 | 1472 | 1725 | 983 | 966 | 648 | 944 | 1011 |
sal-nov_17 | Morph | 24 | 30 | 27 | 2 | 65 | 41 | 69 | 50 |
sal-nov_18 | Morph/Time | 13 | 89 | 121 | 372 | 3 | 11 | 17 | 219 |
sal-nov_19 | Morph | 8 | 4 | 9 | 0 | 207 | 63 | 107 | 15 |
sal-nov_20 | Time | 70 | 274 | 967 | 5358 | 128 | 213 | 988 | 6078 |
sal-nov_21 | Time | 3472 | 7090 | 12625 | 26369 | 5005 | 4127 | 10188 | 20766 |
sal-nov_22 | Time | 121 | 107 | 56 | 1 | 206 | 71 | 26 | 0 |
Included are miRNA names, differential expression and number of raw reads per stage per morph.